Health
Chemotherapy for rare cancer fine-tuned with organoids – EurekAlert
A patient-specific tumor organoid model developed at Wake Forest is being used to identify the most effective chemotherapy protocol to treat appendix and colon tumors, a personalized medicine approach that is showing promise.
WINSTON-SALEM, NC – Aug. 10, 2020, – A patient-specific tumor organoid model is being used to identify the most effective chemotherapy protocol to treat appendix and colon tumors, a personalized medicine approach that is showing promise. The organoids were created by researchers at the Wake Forest Organoid Research Center (WFORCE), a joint effort by the Wake Forest Institute for Regenerative Medicine (WFIRM) and the Wake Forest Comprehensive Cancer Center.
Treatment for advanced stages of colon…
Continue Reading
